The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients
Open accessAbstract
Major depressive disorder (MDD) is a complex and multi-factorial disorder. Although genetic factors and other molecular aspects of MDD have been widely studied, the underlying pathological mechanisms are still mostly unknown. We sought to investigate the pathophysiology of MDD by identifying and characterising serum molecular differences and their correlation to symptom severity in first onset, antidepressant drug-naïve MDD patients. We performed an exploratory molecular profiling study on serum samples of MDD patients and controls using multiplex immunoassay and label-free liquid chromatography mass spectrometry in data independent mode (LC-MSE). We included two independent cohorts of first onset, antidepressant drug-naïve MDD patients (n = 23 and 15) and matched controls (n = 42 and 21) in our study in order to validate the results. The main outcome included the following list of circulatory molecules changing and/or correlating to symptom severity: angiotensin-converting enzyme, acute phase proteins (e.g. ferritin and serotransferrin), brain-derived neurotrophic factor, complement component C4-B, cortisol, cytokines (e.g. macrophage migration inhibitory factor and interleukin-16), extracellular newly identified receptor for advanced glycosylation end products-binding protein, growth hormone and superoxide dismutase-1. This study provides evidence of an increased pro-inflammatory and oxidative stress response, followed by a hyperactivation of the HPA-axis in the acute stages of first onset MDD, as well as a dysregulation in growth factor pathways. These findings help to elucidate MDD related pathways in more detail and further studies may lead to identification of novel drug targets, including components of the inflammatory and oxidative stress response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“interleukin 16 protein levels have been reported to be altered in a molecular profiling study on serum samples of MDD patients (Stelzhammer et al., 2014) and to be associated with symptom severity in schizophrenia (Schwarz et al., 2012).”
From Epigenome-wide DNA methylation in unipolar depression: predictive biomarker of antidepressant treatment response? (2024) · cites this paper as Stelzhammer et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2000) · doi:10.32614/r.manuals · Cited by 355,893
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
Macrophage migration inhibitory factor: a regulator of innate immunity
Calandra, T., & Roger, T. (2003) · Nature reviews. Immunology · doi:10.1038/nri1200 · Cited by 1,782
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617
Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W. (1984) · Science · doi:10.1126/science.6334362 · Cited by 1,485
Sen, S., Duman, R., & Sanacora, G. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.005 · Cited by 1,232
Brunoni, A. R., Lopes, M., & Fregni, F. (2008) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009309 · Cited by 972
Bilici, M., Efe, H., Köroğlu, M. A., Uydu, H. A., Bekaroğlu, M., & Değer, O. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00199-3 · Cited by 718
D, M. F. M., & Kendler, K. S. (2000) · Neuron · doi:10.1016/s0896-6273(00)00112-4 · Cited by 654
Li, G., Vissers, J. P. C., Silva, J. C., Golick, D., Gorenstein, M. V., & Geromanos, S. J. (2009) · PROTEOMICS · doi:10.1002/pmic.200800564 · Cited by 556
Research works printed but not linked: 5
- 2013, Biochim Biophys Acta, 1836, 245
- 2010, Curr Opin Investig Drugs, 11, 31
- 2007, Actas Esp Psiquiatr, 35, 249
- 2009, Psychiatry (Edgmont), 6, 18
- 2010, Biomark Insights, 5, 39
Cited by
Sorted by citations
Items 101–105 of 105
Proteomic biomarkers for bipolar disorder
Muneer, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821398-8.00021-7
Fourrier, C., Toben, C. G., & Baune, B. T. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108539623.016
Clinical Biochemistry of the Mind
Pellegrini, S., & Pietrini, P. (2023) · Springer eBooks · doi:10.1007/978-3-031-24958-7_41
de Azevedo, S. C., Feiten, J. G., Fleck, M. P., & Caldieraro, M. A. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.01.039
Woo, H. I., Park, J., Lim, S.-W., Kim, D. K., & Lee, S.-Y. (2021) · Figshare · doi:10.6084/m9.figshare.13585473
Metadata
- Authors
- Stelzhammer, V., Haenisch, F., Chan, M. K., Cooper, J. D., Steiner, J., Steeb, H., Martins-de-Souza, D., Rahmoune, H., Guest, P. C., & Bahn, S.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- Bahn, Sabine
- ORCID
- Venue
- The International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-06-05
- Volume
- 17
- Issue
- 10
- Pages
- 1599-1608
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W2117492847
- Cited by
- 105
- References
- 45
- Citations by year
- 2025: 4 · 2024: 6 · 2023: 7 · 2022: 9 · 2021: 13 · 2020: 8 · 2019: 5 · 2018: 9 · 2017: 14 · 2016: 19 · 2015: 10 · 2014: 1
- FWCI
- 10.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Americanae (AECID Library) (submittedVersion, other-oa)
- Open access LMU (Ludwid Maxmilian's Universitat Munchen) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- major depressive disorder, first-episode depression, serum proteomics, biomarkers, symptom severity, inflammation, oxidative stress, hypothalamic-pituitary-adrenal axis, cortisol, cytokines, macrophage migration inhibitory factor, interleukin-16, angiotensin-converting enzyme, ferritin, brain-derived neurotrophic factor, complement C4B, growth hormone, superoxide dismutase 1
- MeSH terms
- Adult, Analysis of Variance, Blood Proteins, Chromatography, Liquid, Complement System Proteins, Major Depressive Disorder, Depressive Disorder, Major, Female, Humans, Hydrocortisone, Immunoassay, Peptidyl-Dipeptidase A, Male, Middle Aged, Psychiatric Status Rating Scales, Mass Spectrometry, Statistics as Topic, Case-Control Studies, Cytokines, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
